London, United Kingdom

Charles Swanton

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Charles Swanton in Cancer Research

Introduction

Charles Swanton is a prominent inventor based in London, GB, renowned for his groundbreaking contributions to cancer research. With a total of two patents to his name, Swanton's work focuses on understanding and treating cancer more effectively through advanced methodologies.

Latest Patents

Swanton's most recent patents encompass critical innovations in the field of oncology. The first patent, titled "Analysis of HLA alleles in tumours and the uses thereof," presents a novel method for determining whether an HLA allele is lost in a tumor. This method involves measuring the specific copy number of the HLA allele within the tumor. Additionally, this invention outlines a treatment approach for cancer by targeting a neoantigen that is predicted to be presented by an HLA molecule that remains intact.

The second patent, "Immune checkpoint intervention in cancer," introduces valuable methods for identifying cancer patients suitable for immune checkpoint treatments. This patent also describes techniques for predicting or determining the prognosis of cancer patients, positioning Swanton as a pivotal figure in enhancing cancer treatment strategies.

Career Highlights

Throughout his career, Charles Swanton has collaborated with notable organizations, including Cancer Research Technology Limited and The Francis Crick Institute Limited. His work at these institutions reflects a strong commitment to advancing research in cancer biology and therapy.

Collaborations

In his professional journey, Swanton has worked alongside distinguished colleagues such as Nicholas McGranahan and Rachel Rosenthal. Their collaboration further amplifies the impact of his research innovations and advancements within the scientific community.

Conclusion

Charles Swanton's contributions to cancer research, underscored by his innovative patents, exemplify his dedication to improving cancer diagnostics and treatments. His work not only furthers understanding of tumor biology but also signifies a meaningful step toward enhancing patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…